Aclaris Therapeutics's market cap is currently $199.33M. The company's EPS TTM is $-0.13; its P/E ratio is ―; Aclaris Therapeutics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
